PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024. More detail to come.Additional information on Diabetes New Zealand website and the Pharmac Websites
You have nothing in your cart.
If you know the product code enter it here
If you know the product code enter it into the search field
PE/Cy5 anti-mouse F4/80, 100 μg
PE/Cy5 anti-mouse F4/80, 25 μg
PE/Cy5 anti-mouse I-A/I-E, 100 μg
PE/Cy5 anti-mouse I-A/I-E, 25 μg
PE/Cy5 anti-mouse IL-21 Receptor, 100 μg
PE/Cy5 anti-mouse Ly-6A/E (Sca-1), 100 μg
PE/Cy5 anti-mouse Ly-6A/E (Sca-1), 25 μg
PE/Cy5 anti-mouse Ly-6G/Ly-6C (Gr-1), 100 μg
PE/Cy5 anti-mouse Ly-6G/Ly-6C (Gr-1), 25 μg
PE/Cy5 anti-mouse NK-1.1, 100 μg
PE/Cy5 anti-mouse NK-1.1, 25 μg
PE/Cy5 anti-mouse TCR β chain, 100 μg
PE/Cy5 anti-mouse TCR β chain, 25 μg
PE/Cy5 anti-mouse TER-119/Erythroid Cells, 100 μg
PE/Cy5 anti-mouse TER-119/Erythroid Cells, 25 μg
PE/Cy5 anti-mouse/human CD11b, 100 μg